Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Hemant Surgical Industries Acquisition Worth ₹19.99 Cr

Hemant Surgical Industries will acquire a 66.66% stake in Lifesenz Cancer Research Labs for ₹19.99 Crore. The acquisition strengthens its healthcare and cancer diagnostic segments.

Key figures
Value₹19.99 Cr
Execution periodOn or before September 30, 2026
Source

BSE filing, BSE: 543916. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Hemant Surgical Industries Ltd: key numbers

Share price
₹572.55
Market cap
₹746.5 Cr
Revenue (annual)
₹231.8 Cr
Net profit (annual)
₹18.19 Cr
P/E (TTM)
41.0×Sector 52.0×
Promoter holding
52.83%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Hemant Surgical Industries Ltd

All →

Other acquisition announcements

All →